| Drug Name: | ibritumomab tiuxetan (206181-63-7) |
|---|---|
| PubChem ID: | 74890578 |
| SMILES: | CC(CN(C[C@H](CC1=CC=C(C=C1)NC(=O)NC)N(CC(=O)O)CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O |
| InchiKey: | RTQWWZBSTRGEAV-PKHIMPSTSA-N |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 569.568 |
| LogP | : | -0.9335 |
| Ring Count | : | 1 |
| Hydrogen Bond Acceptor Count | : | 9 |
| Hydrogen Bond Donor Count | : | 7 |
| Total Polar Surface Area | : | 237.35 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category